TY  - JOUR
AU  - Rosell, Rafael
AU  - Karachaliou, Niki
AU  - Codony-Servat, Carles
AU  - Ito, Masaoki
PY  - 2018
TI  - Inhibition of MEK, a canonical KRAS pathway effector in KRAS mutant NSCLC
JF  - Translational Lung Cancer Research; Vol 7, Supplement 3 (September 26, 2018): Translational Lung Cancer Research1
Y2  - 2018
KW  - 
N2  - KRAS mutant NSCLC cells require active nuclear export of Iκβα (also known as NFKBIA), a negative regulatory protein of NF-κB signaling, for maintaining survival signaling (1-3).  Nuclear export receptor XPO1 correlates with KRAS mutation status.
UR  - https://tlcr.amegroups.org/article/view/20503